41 related articles for article (PubMed ID: 38492016)
1. Multiple ions control astroglial excitability, or "Nein, Kalzium, ist NICHT alles".
Verkhratsky A; Rose CR
Acta Physiol (Oxf); 2024 Apr; 240(4):e14120. PubMed ID: 38391057
[No Abstract] [Full Text] [Related]
2. [Die ossäre Dysplasie: ein radiologischer Zufallsbefund].
Ducommun J; Bornstein MM; Suter VGA
Swiss Dent J; 2018 Feb; 128():142-143. PubMed ID: 29533056
[No Abstract] [Full Text] [Related]
3. Safety and Efficacy of Re-irradiation With Carbon-ion Radiotherapy for Pelvic Recurrence of Rectal Cancer After Preoperative Chemoradiotherapy: A Retrospective Analysis.
Shiba S; Okamoto M; Shibuya K; Okazaki S; Kobayashi D; Miyasaka Y; Ohno T
In Vivo; 2022; 36(5):2473-2480. PubMed ID: 36099090
[TBL] [Abstract][Full Text] [Related]
4. Excluding external iliac node irradiation during neoadjuvant radiotherapy decreases lower intestinal toxicity without compromising efficacy in T4b rectal cancer patients with tumours involving the anterior structures.
Li A; Mao M; Chen R; Chi P; Huang Y; Wu J; Xu B
Discov Oncol; 2024 Mar; 15(1):76. PubMed ID: 38492016
[TBL] [Abstract][Full Text] [Related]
5. Necessity of external iliac lymph nodes and inguinal nodes radiation in rectal cancer with anal canal involvement.
Zheng R; Zhang Y; Chen R; Guan B; Lin Y; Wang B; Li X; Chi P; Chen X; Xu B
BMC Cancer; 2022 Jun; 22(1):657. PubMed ID: 35701738
[TBL] [Abstract][Full Text] [Related]
6. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
[No Abstract] [Full Text] [Related]
7. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
8. Excluding the ischiorectal fossa irradiation during neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy followed by abdominoperineal resection decreases perineal complications in patients with lower rectal cancer.
Song M; Geng J; Wang L; Li Y; Zhu X; Li X; Mi L; Wu A; Peng Y; Yao Y; Zhang Y; Wang H; Shi C; Cai Y; Wang W
Radiat Oncol; 2019 Aug; 14(1):138. PubMed ID: 31382984
[TBL] [Abstract][Full Text] [Related]
9. Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors.
Meillan N; Orthuon A; Chauchat P; Atlani D; Bouche O; Chaulin B; David C; Deberne M; Debrigode C; Kao W; Keller A; Laharie H; Lamezec B; Lemanski C; Magné N; Mahé MA; Mere P; Moureau-Zabotto L; Peiffert D; Pointreau Y; Quéro L; Racadot S; Roca S; Sargos P; Servagi S; Tang E; Vendrely V; Doyen J; Huguet F
Radiother Oncol; 2021 Aug; 161():198-204. PubMed ID: 34144078
[TBL] [Abstract][Full Text] [Related]
10. Patterns of failure and implications for clinical target volume definition of locally advanced T4b rectal cancer identified with magnetic resonance imaging and treated using neoadjuvant chemoradiotherapy and surgery.
Zhang YZ; Song M; Geng JH; Zhu XG; Li S; Li YH; Cai Y; Wang WH
Radiother Oncol; 2021 Aug; 161():132-139. PubMed ID: 34126137
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects and limitations of chemoradiotherapy in advanced lower rectal cancer focusing on T4b.
Ozaki K; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Iida Y; Ishii H; Yokoyama Y; Anzai H; Sonoda H; Sugihara K; Ishihara S
Int J Colorectal Dis; 2021 Jul; 36(7):1525-1534. PubMed ID: 33937942
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
Conroy T; Bosset JF; Etienne PL; Rio E; François É; Mesgouez-Nebout N; Vendrely V; Artignan X; Bouché O; Gargot D; Boige V; Bonichon-Lamichhane N; Louvet C; Morand C; de la Fouchardière C; Lamfichekh N; Juzyna B; Jouffroy-Zeller C; Rullier E; Marchal F; Gourgou S; Castan F; Borg C;
Lancet Oncol; 2021 May; 22(5):702-715. PubMed ID: 33862000
[TBL] [Abstract][Full Text] [Related]
13. Cancer statistics, 2020.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2020 Jan; 70(1):7-30. PubMed ID: 31912902
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
